PROM1 and glioblastoma: Notably, CD133+ glioblastoma cell-induced tumors expressed higher levels of EGFR, Ang2, MMP2 and MMP9 proteins compared with CD133− cell-induced tumors, suggesting that CD133+ cell-induced tumors have a higher degree of malignancy.